StockpollyBeta
Get App
Delisting riskPopularity #4,297
ADVB · NASDAQ · Medical - Diagnostics & Research

Advanced Biomed (ADVB)

Financial-market AI systems with biomedical R&D pending sale.

$6.46
vs last close+0.08 (+1.25%)

In millions of USD, except per-share figures

In millionsQ4 FY23Jun 2023Q1 FY24Sep 2023Q2 FY24Dec 2023Q3 FY24Mar 2024Q4 FY24Jun 2024Q1 FY25Sep 2024Q2 FY25Dec 2024Q3 FY25Mar 2025Q4 FY25Jun 2025Q1 FY26Sep 2025Q2 FY26Dec 2025Q3 FY26Mar 2026
Cost of revenue000000—0—0——
Gross profit000000—0—0—0
101011—10101
Research & development000000—0—0—0
000000—000—0
Selling & marketing000000000000
General & administrative000000000000
Other expenses000000—0—0—0
Operating income−10−10−1−1—−10−10−1
−101000—−10000
Interest income000000—0—0—0
Interest expense000000000000
Other non-operating income000000000000
Income before tax−2−100−100−10000
Net income from continuing operations−2−100−100−10000
Discontinued operations0000000000—0
Net income−2−100−100−10000
EPS, basic−$0.05−$0.02−$0.00−$0.04−$0.04−$0.01−$0.03−$0.04−$0.02−$0.01$0.20−$0.38
EPS, diluted−$0.05−$0.02−$0.00−$0.04−$0.04−$0.01−$0.03−$0.04−$0.02−$0.01$0.20−$0.38
Weighted average shares, basic111111111111
Weighted average shares, diluted111111111111
EBITDA−10−1000—−1—0—0
Depreciation & amortization000000—0—0—0
EBIT−10−10−1−1—−10−100